These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 2832912

  • 1. Interactions between pipecuronium and suxamethonium in the dog.
    Jones RS.
    Res Vet Sci; 1987 Nov; 43(3):308-12. PubMed ID: 2832912
    [Abstract] [Full Text] [Related]

  • 2. Effect of prior administration of suxamethonium on non-depolarising muscle relaxants in the dog.
    Jones RS, Gleed RD.
    Res Vet Sci; 1984 Jan; 36(1):43-7. PubMed ID: 6709976
    [Abstract] [Full Text] [Related]

  • 3. Interactions between vecuronium and suxamethonium in the dog.
    Jones RS.
    Res Vet Sci; 1986 Jul; 41(1):93-7. PubMed ID: 2876469
    [Abstract] [Full Text] [Related]

  • 4. Interaction between atracurium and suxamethonium in the dog.
    Jones RS.
    Res Vet Sci; 1986 May; 40(3):299-302. PubMed ID: 3755541
    [Abstract] [Full Text] [Related]

  • 5. Observations on the neuromuscular blocking action of pipecuronium in the dog.
    Jones RS.
    Res Vet Sci; 1987 Jul; 43(1):101-3. PubMed ID: 2820005
    [Abstract] [Full Text] [Related]

  • 6. Effect of prior administration of a non-depolarising muscle relaxant on the action of suxamethonium in the dog.
    Jones RS, Gleed RD.
    Res Vet Sci; 1984 May; 36(3):348-53. PubMed ID: 6463378
    [Abstract] [Full Text] [Related]

  • 7. Effects of respiratory and metabolic alkalosis and acidosis on pipecuronium neuromuscular block.
    Biró K.
    Eur J Pharmacol; 1988 Sep 23; 154(3):329-33. PubMed ID: 2853060
    [Abstract] [Full Text] [Related]

  • 8. Evaluation of the neuromuscular blocking effect of Arduan.
    Tassonyi E.
    Ther Hung; 1983 Sep 23; 31(1):13-7. PubMed ID: 6100820
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The pharmacology of a new short-acting, non-depolarising muscle relaxant steroid (RGH-4201).
    Biró K, Kárpáti E.
    Arzneimittelforschung; 1981 Sep 23; 31(11):1918-24. PubMed ID: 6172135
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacological study of a new competitive neuromuscular blocking steroid, pipecurium bromide.
    Kárpáti E, Biró K.
    Arzneimittelforschung; 1980 Sep 23; 30(2a):346-57. PubMed ID: 6155921
    [Abstract] [Full Text] [Related]

  • 14. [Use of the steroid muscle relaxant arduan in surgical interventions on the musculoskeletal system].
    Pashchuk AIu, Tiutiunnik IF, Zgola IA.
    Ortop Travmatol Protez; 1984 Dec 23; (12):20-2. PubMed ID: 6098888
    [No Abstract] [Full Text] [Related]

  • 15. Observations made during operations performed under Arduan relaxation.
    Horváth I, Illés T.
    Ther Hung; 1984 Dec 23; 32(1):13-5. PubMed ID: 6100828
    [No Abstract] [Full Text] [Related]

  • 16. Dose-response relation and time course of action of pipecuronium bromide in humans anesthetized with nitrous oxide and isoflurane, halothane, or droperidol and fentanyl.
    Wierda JM, Richardson FJ, Agoston S.
    Anesth Analg; 1989 Mar 23; 68(3):208-13. PubMed ID: 2537588
    [Abstract] [Full Text] [Related]

  • 17. [Pharmacologic effects of pipecuronium bromide (Arduan)].
    Kárpáti E, Bíró K.
    Acta Pharm Hung; 1992 May 23; 62(3):121-6. PubMed ID: 1323913
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Respiration paralysing and circulatory effects of a new non-depolarizing relaxant, pipecurium bromide, in anaesthetized dogs.
    Pulay I, Alánt O, Darvas K, Weltner J, Zétény Z.
    Arzneimittelforschung; 1980 May 23; 30(2a):358-60. PubMed ID: 6248078
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.